Brief: Biorestorative Therapies And Northwell Health Enter Into Agreement To Participate In The Company’S Phase 2 Clinical Trial
08/05/2023 15:34
May 8 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES AND NORTHWELL HEALTH ENTER INTO
AGREEMENT TO PARTICIPATE IN THE COMPANY’S PHASE 2 CLINICAL TRIAL
Source text for Eikon: ID:nGNX60WWyp
Further company coverage: BRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM